Two big medicine companies are fighting in a United States court. The first company is Novo Nordisk. The second company is Eli Lilly. Novo Nordisk says that Eli Lilly is using false advertisements. They say Eli Lilly's ads for weight-loss and diabetes drugs are not true.
Novo Nordisk makes famous drugs called Ozempic and Wegovy. They claim that Eli Lilly uses old scientific studies to make its drugs look better. Novo Nordisk says Eli Lilly compares its high doses to the lower doses of Novo Nordisk drugs. This makes Eli Lilly's products look more effective than they really are.
Novo Nordisk wants the court to stop these advertisements. They also want Eli Lilly to run new ads that show the correct information. This is a big fight because the weight-loss market is growing very fast. Experts say this market could be worth more than $100 billion by the year 2030.
Eli Lilly says these claims are not true. They say their advertisements are honest and use real science. They use a special study called the Surmount-5 trial to prove their drugs, Mounjaro and Zepbound, are good. They believe their scientific methods are correct.
Both companies want to win this large market. This legal battle is important because it will show how companies can compare their medicines in ads. The court will now decide if the advertisements are scientific or if they are misleading to the public.